The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?

Serotonin reuptake inhibitors (SRIs) are often prescribed during pregnancy. Previous studies that found an increased risk of congenital anomalies, particularly congenital heart anomalies (CHA), with SRI use during pregnancy have created concern among pregnant women and healthcare professionals about...

Descripción completa

Detalles Bibliográficos
Autores principales: Daud, Aizati N. A., Bergman, Jorieke E. H., Kerstjens-Frederikse, Wilhelmina S., Groen, Henk, Wilffert, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000730/
https://www.ncbi.nlm.nih.gov/pubmed/27529241
http://dx.doi.org/10.3390/ijms17081333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000730/
https://www.ncbi.nlm.nih.gov/pubmed/27529241
http://dx.doi.org/10.3390/ijms17081333

Ejemplares similares